

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ribosomal small subunit assembly (GO:0000028) | 4.32786079 |
| 2 | cullin deneddylation (GO:0010388) | 3.96811463 |
| 3 | protein deneddylation (GO:0000338) | 3.90041791 |
| 4 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.64139414 |
| 5 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.64139414 |
| 6 | rRNA modification (GO:0000154) | 3.58832970 |
| 7 | pseudouridine synthesis (GO:0001522) | 3.54839370 |
| 8 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.52159770 |
| 9 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.51237800 |
| 10 | DNA catabolic process, exonucleolytic (GO:0000738) | 3.46000522 |
| 11 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.42133754 |
| 12 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 3.36162722 |
| 13 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 3.36162722 |
| 14 | formation of translation preinitiation complex (GO:0001731) | 3.34954843 |
| 15 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.33527803 |
| 16 | natural killer cell mediated immunity (GO:0002228) | 3.33527803 |
| 17 | DNA strand elongation (GO:0022616) | 3.31431734 |
| 18 | mannosylation (GO:0097502) | 3.30902293 |
| 19 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.27231972 |
| 20 | maturation of SSU-rRNA (GO:0030490) | 3.22013386 |
| 21 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.21472538 |
| 22 | DNA deamination (GO:0045006) | 3.20195994 |
| 23 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 3.17429573 |
| 24 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.13397480 |
| 25 | maturation of 5.8S rRNA (GO:0000460) | 3.13394391 |
| 26 | regulation of helicase activity (GO:0051095) | 3.09398015 |
| 27 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.07678798 |
| 28 | DNA double-strand break processing (GO:0000729) | 3.07536571 |
| 29 | positive regulation of ligase activity (GO:0051351) | 3.06467243 |
| 30 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.05342132 |
| 31 | NIK/NF-kappaB signaling (GO:0038061) | 3.05187590 |
| 32 | somatic recombination of immunoglobulin genes involved in immune response (GO:0002204) | 3.05148085 |
| 33 | somatic diversification of immunoglobulins involved in immune response (GO:0002208) | 3.05148085 |
| 34 | isotype switching (GO:0045190) | 3.05148085 |
| 35 | viral transcription (GO:0019083) | 3.01460989 |
| 36 | establishment of integrated proviral latency (GO:0075713) | 2.97716556 |
| 37 | telomere maintenance via recombination (GO:0000722) | 2.97711317 |
| 38 | regulation of mitochondrial translation (GO:0070129) | 2.96082858 |
| 39 | respiratory chain complex IV assembly (GO:0008535) | 2.95022965 |
| 40 | peptidyl-histidine modification (GO:0018202) | 2.94837297 |
| 41 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.94520485 |
| 42 | translational termination (GO:0006415) | 2.93525829 |
| 43 | regulation of RIG-I signaling pathway (GO:0039535) | 2.92409997 |
| 44 | protein complex biogenesis (GO:0070271) | 2.91696849 |
| 45 | DNA replication initiation (GO:0006270) | 2.90752094 |
| 46 | ribosomal small subunit biogenesis (GO:0042274) | 2.89872530 |
| 47 | GMP metabolic process (GO:0046037) | 2.89856588 |
| 48 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.89615483 |
| 49 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.88533042 |
| 50 | rRNA methylation (GO:0031167) | 2.88078744 |
| 51 | protein targeting to mitochondrion (GO:0006626) | 2.87057706 |
| 52 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.84586175 |
| 53 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.84447219 |
| 54 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.83109289 |
| 55 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.82787067 |
| 56 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.82787067 |
| 57 | * transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.82597160 |
| 58 | * termination of RNA polymerase III transcription (GO:0006386) | 2.82597160 |
| 59 | CENP-A containing nucleosome assembly (GO:0034080) | 2.82487752 |
| 60 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.82327543 |
| 61 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.82327543 |
| 62 | NADH dehydrogenase complex assembly (GO:0010257) | 2.82327543 |
| 63 | regulation of mitotic spindle checkpoint (GO:1903504) | 2.81124579 |
| 64 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 2.81124579 |
| 65 | protein localization to kinetochore (GO:0034501) | 2.81029154 |
| 66 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.80909561 |
| 67 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.80568568 |
| 68 | nucleobase biosynthetic process (GO:0046112) | 2.80371848 |
| 69 | translational elongation (GO:0006414) | 2.77704023 |
| 70 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.75326474 |
| 71 | tRNA aminoacylation for protein translation (GO:0006418) | 2.75265376 |
| 72 | purine nucleobase biosynthetic process (GO:0009113) | 2.73289268 |
| 73 | establishment of viral latency (GO:0019043) | 2.73187599 |
| 74 | somatic diversification of immunoglobulins (GO:0016445) | 2.72567712 |
| 75 | histone H2A acetylation (GO:0043968) | 2.72407161 |
| 76 | chromatin remodeling at centromere (GO:0031055) | 2.72405367 |
| 77 | positive regulation of cell cycle arrest (GO:0071158) | 2.71831072 |
| 78 | regulation of ligase activity (GO:0051340) | 2.71211553 |
| 79 | nuclear pore complex assembly (GO:0051292) | 2.71098137 |
| 80 | ribosome biogenesis (GO:0042254) | 2.70787590 |
| 81 | replication fork processing (GO:0031297) | 2.70119218 |
| 82 | cytochrome complex assembly (GO:0017004) | 2.70074514 |
| 83 | amino acid activation (GO:0043038) | 2.69713245 |
| 84 | tRNA aminoacylation (GO:0043039) | 2.69713245 |
| 85 | IMP biosynthetic process (GO:0006188) | 2.69185907 |
| 86 | mitochondrial RNA metabolic process (GO:0000959) | 2.68416682 |
| 87 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.68274577 |
| 88 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.67463952 |
| 89 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.67330184 |
| 90 | translational initiation (GO:0006413) | 2.66722772 |
| 91 | mitotic nuclear envelope disassembly (GO:0007077) | 2.66467441 |
| 92 | mitotic recombination (GO:0006312) | 2.66295802 |
| 93 | purine nucleotide salvage (GO:0032261) | 2.65523375 |
| 94 | synapsis (GO:0007129) | 2.65004670 |
| 95 | negative regulation of protein ubiquitination (GO:0031397) | 2.64412880 |
| 96 | somatic recombination of immunoglobulin gene segments (GO:0016447) | 2.62855210 |
| 97 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.62267989 |
| 98 | cell cycle G1/S phase transition (GO:0044843) | 2.61631469 |
| 99 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.61631469 |
| 100 | B cell mediated immunity (GO:0019724) | 2.61228141 |
| 101 | non-recombinational repair (GO:0000726) | 2.60396947 |
| 102 | telomere maintenance via telomere lengthening (GO:0010833) | 2.59450016 |
| 103 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.58875331 |
| 104 | protein localization to chromosome, centromeric region (GO:0071459) | 2.58414699 |
| 105 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.58062425 |
| 106 | ribosomal large subunit biogenesis (GO:0042273) | 2.57663092 |
| 107 | mitotic metaphase plate congression (GO:0007080) | 2.57300739 |
| 108 | DNA unwinding involved in DNA replication (GO:0006268) | 2.55806104 |
| 109 | sequestering of actin monomers (GO:0042989) | 2.55139629 |
| 110 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.54950611 |
| 111 | DNA replication checkpoint (GO:0000076) | 2.54202855 |
| 112 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.53801515 |
| 113 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.53711235 |
| 114 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.53375284 |
| 115 | immunoglobulin mediated immune response (GO:0016064) | 2.52462886 |
| 116 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.52141858 |
| 117 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.50914566 |
| 118 | cellular response to interferon-beta (GO:0035458) | 2.48172650 |
| 119 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.47401504 |
| 120 | type I interferon signaling pathway (GO:0060337) | 2.44389170 |
| 121 | cellular response to type I interferon (GO:0071357) | 2.44389170 |
| 122 | response to type I interferon (GO:0034340) | 2.42944191 |
| 123 | protein targeting to ER (GO:0045047) | 2.42260587 |
| 124 | cotranslational protein targeting to membrane (GO:0006613) | 2.42002100 |
| 125 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.41389833 |
| 126 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.41339905 |
| 127 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.39688118 |
| 128 | regulation of B cell differentiation (GO:0045577) | 2.39183635 |
| 129 | positive regulation of B cell differentiation (GO:0045579) | 2.39114212 |
| 130 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.39000330 |
| 131 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.38821843 |
| 132 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.38752533 |
| 133 | nuclear envelope disassembly (GO:0051081) | 2.37639535 |
| 134 | membrane disassembly (GO:0030397) | 2.37639535 |
| 135 | T cell apoptotic process (GO:0070231) | 2.36509954 |
| 136 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.36089564 |
| 137 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.36089564 |
| 138 | defense response to protozoan (GO:0042832) | 2.34640335 |
| 139 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.34481168 |
| 140 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.34481168 |
| 141 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.34481168 |
| 142 | neutrophil activation involved in immune response (GO:0002283) | 2.34365533 |
| 143 | regulation of necroptotic process (GO:0060544) | 2.33790325 |
| 144 | viral life cycle (GO:0019058) | 2.33598098 |
| 145 | IMP metabolic process (GO:0046040) | 2.30467775 |
| 146 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.30451558 |
| 147 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.29689227 |
| 148 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.29689227 |
| 149 | regulation of response to interferon-gamma (GO:0060330) | 2.29183964 |
| 150 | proteasome assembly (GO:0043248) | 2.28907506 |
| 151 | cellular protein complex disassembly (GO:0043624) | 2.28803093 |
| 152 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.28162069 |
| 153 | ribosome assembly (GO:0042255) | 2.28033218 |
| 154 | protein localization to endoplasmic reticulum (GO:0070972) | 2.27693404 |
| 155 | regulation of translation in response to stress (GO:0043555) | 2.26634756 |
| 156 | rRNA processing (GO:0006364) | 2.25955566 |
| 157 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.25789122 |
| 158 | negative regulation of ligase activity (GO:0051352) | 2.25404351 |
| 159 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.25404351 |
| 160 | response to interferon-beta (GO:0035456) | 2.25091463 |
| 161 | rRNA metabolic process (GO:0016072) | 2.21598321 |
| 162 | telomere organization (GO:0032200) | 2.21548496 |
| 163 | metaphase plate congression (GO:0051310) | 2.21261079 |
| 164 | establishment of chromosome localization (GO:0051303) | 2.21214268 |
| 165 | telomere maintenance (GO:0000723) | 2.21086342 |
| 166 | leukocyte aggregation (GO:0070486) | 2.20888910 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.80932319 |
| 2 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.25266647 |
| 3 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.12719161 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.96040709 |
| 5 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.87937989 |
| 6 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.77893325 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.50179876 |
| 8 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.44440791 |
| 9 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.43903257 |
| 10 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.41269492 |
| 11 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.40038041 |
| 12 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.31769026 |
| 13 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.29654481 |
| 14 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.26118849 |
| 15 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.21845230 |
| 16 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.14293489 |
| 17 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.12889027 |
| 18 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.10918317 |
| 19 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.10655813 |
| 20 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.06518510 |
| 21 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.06321515 |
| 22 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.00965221 |
| 23 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.99122888 |
| 24 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.99011829 |
| 25 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.98135442 |
| 26 | MYC_22102868_ChIP-Seq_BL_Human | 1.97353813 |
| 27 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.96848334 |
| 28 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.84783296 |
| 29 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.83294330 |
| 30 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.82664617 |
| 31 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.81685465 |
| 32 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.81448064 |
| 33 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.73833010 |
| 34 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.72834402 |
| 35 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.72015883 |
| 36 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.70748145 |
| 37 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.70573205 |
| 38 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.68632290 |
| 39 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.68101022 |
| 40 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.66508252 |
| 41 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.60013690 |
| 42 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.59872299 |
| 43 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.59846866 |
| 44 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.59399531 |
| 45 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.56853246 |
| 46 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55838711 |
| 47 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.53277684 |
| 48 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.52428417 |
| 49 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.51455351 |
| 50 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.49462854 |
| 51 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.47596512 |
| 52 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.46374114 |
| 53 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.45624551 |
| 54 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.44729522 |
| 55 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.43583489 |
| 56 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.42243790 |
| 57 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41372599 |
| 58 | MAF_26560356_Chip-Seq_TH1_Human | 1.40413862 |
| 59 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.38642443 |
| 60 | MYB_26560356_Chip-Seq_TH2_Human | 1.37606186 |
| 61 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.37512761 |
| 62 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.36817571 |
| 63 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.33075812 |
| 64 | MYB_26560356_Chip-Seq_TH1_Human | 1.32674057 |
| 65 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.31987428 |
| 66 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.29987200 |
| 67 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.29754151 |
| 68 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.29675301 |
| 69 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.28695614 |
| 70 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.27396143 |
| 71 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.25549528 |
| 72 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.25525653 |
| 73 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.25247832 |
| 74 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.23911862 |
| 75 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.23773806 |
| 76 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.22283102 |
| 77 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.22053644 |
| 78 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.20484129 |
| 79 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.20083324 |
| 80 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.19983489 |
| 81 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.19199721 |
| 82 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.18121052 |
| 83 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.17977228 |
| 84 | UTX_26944678_Chip-Seq_JUKART_Human | 1.17452042 |
| 85 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.16396597 |
| 86 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.16124993 |
| 87 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.15384698 |
| 88 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.13308761 |
| 89 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.13146616 |
| 90 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.12301327 |
| 91 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.10848417 |
| 92 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.09299658 |
| 93 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.08443328 |
| 94 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.07826310 |
| 95 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.07024984 |
| 96 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.06884252 |
| 97 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.06413994 |
| 98 | GATA1_22025678_ChIP-Seq_K562_Human | 1.06358044 |
| 99 | MAF_26560356_Chip-Seq_TH2_Human | 1.05352538 |
| 100 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.04694736 |
| 101 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.04570725 |
| 102 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.02947810 |
| 103 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.02454697 |
| 104 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.01657582 |
| 105 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.01162041 |
| 106 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.00309432 |
| 107 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.97492359 |
| 108 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.96411456 |
| 109 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.96331534 |
| 110 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.95728983 |
| 111 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.95305940 |
| 112 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.94361928 |
| 113 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.93810456 |
| 114 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.93697788 |
| 115 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.92501422 |
| 116 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91481021 |
| 117 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91082423 |
| 118 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.89510962 |
| 119 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.87223272 |
| 120 | GATA3_26560356_Chip-Seq_TH2_Human | 0.86860292 |
| 121 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.85955742 |
| 122 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.84142436 |
| 123 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.82545707 |
| 124 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.74134279 |
| 125 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.73986651 |
| 126 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.72012916 |
| 127 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.71963293 |
| 128 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.70389587 |
| 129 | VDR_22108803_ChIP-Seq_LS180_Human | 0.68446992 |
| 130 | EWS_26573619_Chip-Seq_HEK293_Human | 0.68211057 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000372_irregular_coat_pigmentation | 3.57701770 |
| 2 | MP0003693_abnormal_embryo_hatching | 3.42772916 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.34706523 |
| 4 | MP0000685_abnormal_immune_system | 2.74354060 |
| 5 | MP0009785_altered_susceptibility_to | 2.60536931 |
| 6 | MP0003111_abnormal_nucleus_morphology | 2.53805225 |
| 7 | MP0002396_abnormal_hematopoietic_system | 2.53303127 |
| 8 | MP0003077_abnormal_cell_cycle | 2.44655914 |
| 9 | MP0010094_abnormal_chromosome_stability | 2.44070400 |
| 10 | MP0003763_abnormal_thymus_physiology | 2.41860627 |
| 11 | MP0005671_abnormal_response_to | 2.36268463 |
| 12 | MP0004957_abnormal_blastocyst_morpholog | 2.33162442 |
| 13 | MP0001800_abnormal_humoral_immune | 2.27824893 |
| 14 | MP0003436_decreased_susceptibility_to | 2.24583990 |
| 15 | MP0009333_abnormal_splenocyte_physiolog | 2.22306235 |
| 16 | MP0005387_immune_system_phenotype | 2.18112058 |
| 17 | MP0001790_abnormal_immune_system | 2.18112058 |
| 18 | MP0008057_abnormal_DNA_replication | 2.13483322 |
| 19 | MP0002452_abnormal_antigen_presenting | 2.11781503 |
| 20 | MP0002398_abnormal_bone_marrow | 2.11326300 |
| 21 | MP0005000_abnormal_immune_tolerance | 2.09380513 |
| 22 | MP0008058_abnormal_DNA_repair | 2.06732082 |
| 23 | MP0005025_abnormal_response_to | 2.03896642 |
| 24 | MP0001819_abnormal_immune_cell | 2.01518356 |
| 25 | MP0002420_abnormal_adaptive_immunity | 2.01208938 |
| 26 | MP0005397_hematopoietic_system_phenotyp | 2.01145756 |
| 27 | MP0001545_abnormal_hematopoietic_system | 2.01145756 |
| 28 | MP0002723_abnormal_immune_serum | 1.99765534 |
| 29 | MP0004147_increased_porphyrin_level | 1.96596808 |
| 30 | MP0008007_abnormal_cellular_replicative | 1.96388840 |
| 31 | MP0006036_abnormal_mitochondrial_physio | 1.95829574 |
| 32 | MP0002148_abnormal_hypersensitivity_rea | 1.94050422 |
| 33 | MP0006035_abnormal_mitochondrial_morpho | 1.88644706 |
| 34 | MP0000490_abnormal_crypts_of | 1.86972103 |
| 35 | MP0010352_gastrointestinal_tract_polyps | 1.83587904 |
| 36 | MP0000716_abnormal_immune_system | 1.82086352 |
| 37 | MP0003950_abnormal_plasma_membrane | 1.80928411 |
| 38 | MP0000689_abnormal_spleen_morphology | 1.79222828 |
| 39 | MP0002722_abnormal_immune_system | 1.78488551 |
| 40 | MP0004808_abnormal_hematopoietic_stem | 1.78275229 |
| 41 | MP0003718_maternal_effect | 1.77921966 |
| 42 | MP0002419_abnormal_innate_immunity | 1.75817770 |
| 43 | MP0005408_hypopigmentation | 1.74066123 |
| 44 | MP0000858_altered_metastatic_potential | 1.69479457 |
| 45 | MP0002429_abnormal_blood_cell | 1.68392551 |
| 46 | MP0002166_altered_tumor_susceptibility | 1.68377006 |
| 47 | MP0001853_heart_inflammation | 1.67229947 |
| 48 | MP0000358_abnormal_cell_content/ | 1.65950760 |
| 49 | MP0010155_abnormal_intestine_physiology | 1.65787042 |
| 50 | MP0002405_respiratory_system_inflammati | 1.61211765 |
| 51 | MP0005171_absent_coat_pigmentation | 1.55430710 |
| 52 | MP0000703_abnormal_thymus_morphology | 1.53321771 |
| 53 | MP0010307_abnormal_tumor_latency | 1.53240376 |
| 54 | MP0001764_abnormal_homeostasis | 1.49215851 |
| 55 | MP0002006_tumorigenesis | 1.44722128 |
| 56 | MP0006082_CNS_inflammation | 1.40139904 |
| 57 | MP0001873_stomach_inflammation | 1.39359909 |
| 58 | MP0002019_abnormal_tumor_incidence | 1.37514963 |
| 59 | MP0005464_abnormal_platelet_physiology | 1.37480654 |
| 60 | MP0001845_abnormal_inflammatory_respons | 1.36250402 |
| 61 | MP0004947_skin_inflammation | 1.34625041 |
| 62 | MP0009278_abnormal_bone_marrow | 1.34208283 |
| 63 | MP0002163_abnormal_gland_morphology | 1.28627299 |
| 64 | MP0003724_increased_susceptibility_to | 1.27374825 |
| 65 | MP0003303_peritoneal_inflammation | 1.26458807 |
| 66 | MP0000350_abnormal_cell_proliferation | 1.25423800 |
| 67 | MP0001730_embryonic_growth_arrest | 1.23119701 |
| 68 | MP0002102_abnormal_ear_morphology | 1.22650097 |
| 69 | MP0006072_abnormal_retinal_apoptosis | 1.22000233 |
| 70 | MP0008995_early_reproductive_senescence | 1.21500061 |
| 71 | MP0000313_abnormal_cell_death | 1.20811011 |
| 72 | MP0003186_abnormal_redox_activity | 1.19559830 |
| 73 | MP0008469_abnormal_protein_level | 1.18206513 |
| 74 | MP0003866_abnormal_defecation | 1.17566237 |
| 75 | MP0001929_abnormal_gametogenesis | 1.16998159 |
| 76 | MP0005310_abnormal_salivary_gland | 1.16059982 |
| 77 | MP0003448_altered_tumor_morphology | 1.08355284 |
| 78 | MP0001119_abnormal_female_reproductive | 1.06074617 |
| 79 | MP0002132_abnormal_respiratory_system | 1.02062499 |
| 80 | MP0008932_abnormal_embryonic_tissue | 1.01703369 |
| 81 | MP0002138_abnormal_hepatobiliary_system | 0.99820600 |
| 82 | MP0009697_abnormal_copulation | 0.99508653 |
| 83 | MP0002210_abnormal_sex_determination | 0.98809902 |
| 84 | MP0005076_abnormal_cell_differentiation | 0.98440663 |
| 85 | MP0008877_abnormal_DNA_methylation | 0.96040894 |
| 86 | MP0005410_abnormal_fertilization | 0.95206962 |
| 87 | MP0003806_abnormal_nucleotide_metabolis | 0.90784186 |
| 88 | MP0003786_premature_aging | 0.90014851 |
| 89 | MP0000015_abnormal_ear_pigmentation | 0.89718784 |
| 90 | MP0003656_abnormal_erythrocyte_physiolo | 0.89430513 |
| 91 | MP0005084_abnormal_gallbladder_morpholo | 0.89269328 |
| 92 | MP0000653_abnormal_sex_gland | 0.88016737 |
| 93 | MP0008872_abnormal_physiological_respon | 0.87473287 |
| 94 | MP0001919_abnormal_reproductive_system | 0.87380541 |
| 95 | MP0009765_abnormal_xenobiotic_induced | 0.86939196 |
| 96 | MP0002080_prenatal_lethality | 0.85541688 |
| 97 | MP0005174_abnormal_tail_pigmentation | 0.84331739 |
| 98 | MP0003984_embryonic_growth_retardation | 0.83480472 |
| 99 | MP0001533_abnormal_skeleton_physiology | 0.83109405 |
| 100 | MP0001672_abnormal_embryogenesis/_devel | 0.81921706 |
| 101 | MP0005380_embryogenesis_phenotype | 0.81921706 |
| 102 | MP0001529_abnormal_vocalization | 0.81610468 |
| 103 | MP0006054_spinal_hemorrhage | 0.81355660 |
| 104 | MP0002088_abnormal_embryonic_growth/wei | 0.80681067 |
| 105 | MP0001145_abnormal_male_reproductive | 0.80550158 |
| 106 | MP0005451_abnormal_body_composition | 0.80500545 |
| 107 | MP0003567_abnormal_fetal_cardiomyocyte | 0.79933242 |
| 108 | MP0002095_abnormal_skin_pigmentation | 0.79643155 |
| 109 | MP0003646_muscle_fatigue | 0.79496589 |
| 110 | MP0009840_abnormal_foam_cell | 0.78213026 |
| 111 | MP0000613_abnormal_salivary_gland | 0.77812547 |
| 112 | MP0001697_abnormal_embryo_size | 0.76722314 |
| 113 | MP0000465_gastrointestinal_hemorrhage | 0.75395113 |
| 114 | MP0003300_gastrointestinal_ulcer | 0.74157800 |
| 115 | MP0005083_abnormal_biliary_tract | 0.73688751 |
| 116 | MP0000371_diluted_coat_color | 0.72456006 |
| 117 | MP0008873_increased_physiological_sensi | 0.72240535 |
| 118 | MP0005253_abnormal_eye_physiology | 0.72108919 |
| 119 | MP0000598_abnormal_liver_morphology | 0.71980131 |
| 120 | MP0005023_abnormal_wound_healing | 0.71611186 |
| 121 | MP0000343_altered_response_to | 0.71071771 |
| 122 | MP0002877_abnormal_melanocyte_morpholog | 0.70145247 |
| 123 | MP0009764_decreased_sensitivity_to | 0.69907100 |
| 124 | MP0002086_abnormal_extraembryonic_tissu | 0.69836051 |
| 125 | MP0009763_increased_sensitivity_to | 0.67973598 |
| 126 | MP0005384_cellular_phenotype | 0.67487191 |
| 127 | MP0002234_abnormal_pharynx_morphology | 0.66745028 |
| 128 | MP0000427_abnormal_hair_cycle | 0.66543696 |
| 129 | MP0001191_abnormal_skin_condition | 0.65259547 |
| 130 | MP0002933_joint_inflammation | 0.64866407 |
| 131 | MP0005075_abnormal_melanosome_morpholog | 0.64621035 |
| 132 | MP0005389_reproductive_system_phenotype | 0.63561249 |
| 133 | MP0000477_abnormal_intestine_morphology | 0.63466695 |
| 134 | MP0005058_abnormal_lysosome_morphology | 0.63032035 |
| 135 | MP0003943_abnormal_hepatobiliary_system | 0.61715263 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormal protein glycosylation (HP:0012346) | 3.89341040 |
| 2 | Abnormal glycosylation (HP:0012345) | 3.89341040 |
| 3 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 3.89341040 |
| 4 | Abnormal protein N-linked glycosylation (HP:0012347) | 3.89341040 |
| 5 | Thrombocytosis (HP:0001894) | 3.84118366 |
| 6 | Eczematoid dermatitis (HP:0000976) | 3.61255324 |
| 7 | Recurrent abscess formation (HP:0002722) | 3.59107218 |
| 8 | IgM deficiency (HP:0002850) | 3.55704303 |
| 9 | Hepatocellular necrosis (HP:0001404) | 3.50859158 |
| 10 | Acute necrotizing encephalopathy (HP:0006965) | 3.50636986 |
| 11 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.46308438 |
| 12 | Increased CSF lactate (HP:0002490) | 3.45292600 |
| 13 | Reticulocytopenia (HP:0001896) | 3.41368499 |
| 14 | Mitochondrial inheritance (HP:0001427) | 3.36710171 |
| 15 | Recurrent fungal infections (HP:0002841) | 3.33020811 |
| 16 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.31419384 |
| 17 | Recurrent viral infections (HP:0004429) | 3.29027415 |
| 18 | Recurrent bacterial skin infections (HP:0005406) | 3.27799540 |
| 19 | Chronic otitis media (HP:0000389) | 3.25740999 |
| 20 | Autoimmune thrombocytopenia (HP:0001973) | 3.21157690 |
| 21 | Acute encephalopathy (HP:0006846) | 3.19702489 |
| 22 | Myositis (HP:0100614) | 3.15246795 |
| 23 | Recurrent bronchitis (HP:0002837) | 3.12633473 |
| 24 | Hepatic necrosis (HP:0002605) | 3.06996759 |
| 25 | Increased serum lactate (HP:0002151) | 3.06488228 |
| 26 | Abnormality of T cell physiology (HP:0011840) | 3.03539693 |
| 27 | Pustule (HP:0200039) | 3.01475629 |
| 28 | Petechiae (HP:0000967) | 2.99872291 |
| 29 | Abnormality of T cells (HP:0002843) | 2.98539109 |
| 30 | Microvesicular hepatic steatosis (HP:0001414) | 2.95336969 |
| 31 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.89423649 |
| 32 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.89423649 |
| 33 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.88917484 |
| 34 | Ependymoma (HP:0002888) | 2.85955492 |
| 35 | Abnormal number of erythroid precursors (HP:0012131) | 2.75497851 |
| 36 | Progressive macrocephaly (HP:0004481) | 2.73814547 |
| 37 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.70703842 |
| 38 | Cerebral edema (HP:0002181) | 2.66938337 |
| 39 | Cutaneous melanoma (HP:0012056) | 2.66225074 |
| 40 | Increased hepatocellular lipid droplets (HP:0006565) | 2.65327315 |
| 41 | Lactic acidosis (HP:0003128) | 2.65198636 |
| 42 | Abnormality of T cell number (HP:0011839) | 2.64994688 |
| 43 | Combined immunodeficiency (HP:0005387) | 2.63820886 |
| 44 | Birth length less than 3rd percentile (HP:0003561) | 2.62849941 |
| 45 | Colon cancer (HP:0003003) | 2.61545006 |
| 46 | Aplastic anemia (HP:0001915) | 2.57584390 |
| 47 | Increased IgM level (HP:0003496) | 2.55299737 |
| 48 | Nasal polyposis (HP:0100582) | 2.55103086 |
| 49 | Chromsome breakage (HP:0040012) | 2.54781497 |
| 50 | Severe combined immunodeficiency (HP:0004430) | 2.53554740 |
| 51 | IgG deficiency (HP:0004315) | 2.52421082 |
| 52 | Vasculitis (HP:0002633) | 2.52071264 |
| 53 | Agnosia (HP:0010524) | 2.50138769 |
| 54 | T lymphocytopenia (HP:0005403) | 2.47017776 |
| 55 | Retrobulbar optic neuritis (HP:0100654) | 2.45611504 |
| 56 | Optic neuritis (HP:0100653) | 2.45611504 |
| 57 | Myelodysplasia (HP:0002863) | 2.45250804 |
| 58 | Granulocytopenia (HP:0001913) | 2.45221069 |
| 59 | Mediastinal lymphadenopathy (HP:0100721) | 2.45009983 |
| 60 | Cellulitis (HP:0100658) | 2.44713181 |
| 61 | Lipid accumulation in hepatocytes (HP:0006561) | 2.44229493 |
| 62 | Cerebral hypomyelination (HP:0006808) | 2.43097734 |
| 63 | Orchitis (HP:0100796) | 2.42478314 |
| 64 | Renal Fanconi syndrome (HP:0001994) | 2.41102968 |
| 65 | Panhypogammaglobulinemia (HP:0003139) | 2.40804248 |
| 66 | Spontaneous hematomas (HP:0007420) | 2.40567645 |
| 67 | Amaurosis fugax (HP:0100576) | 2.39623312 |
| 68 | Meckel diverticulum (HP:0002245) | 2.38378802 |
| 69 | Abnormality of the nasal mucosa (HP:0000433) | 2.38200396 |
| 70 | Pancytopenia (HP:0001876) | 2.38083401 |
| 71 | Lymphoma (HP:0002665) | 2.36479415 |
| 72 | Encephalitis (HP:0002383) | 2.36274098 |
| 73 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.36018926 |
| 74 | Meningitis (HP:0001287) | 2.33213403 |
| 75 | Fatigue (HP:0012378) | 2.32723010 |
| 76 | Abnormality of the anterior horn cell (HP:0006802) | 2.32387279 |
| 77 | Degeneration of anterior horn cells (HP:0002398) | 2.32387279 |
| 78 | Reduced antithrombin III activity (HP:0001976) | 2.31913464 |
| 79 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.30173509 |
| 80 | Chronic obstructive pulmonary disease (HP:0006510) | 2.29567907 |
| 81 | Obstructive lung disease (HP:0006536) | 2.29567907 |
| 82 | Increased intramyocellular lipid droplets (HP:0012240) | 2.28085356 |
| 83 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.27725068 |
| 84 | Abnormality of alanine metabolism (HP:0010916) | 2.27157274 |
| 85 | Hyperalaninemia (HP:0003348) | 2.27157274 |
| 86 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.27157274 |
| 87 | Abnormality of the ileum (HP:0001549) | 2.26857922 |
| 88 | Abnormality of macrophages (HP:0004311) | 2.25954738 |
| 89 | Eosinophilia (HP:0001880) | 2.25794605 |
| 90 | Recurrent skin infections (HP:0001581) | 2.25730198 |
| 91 | Prostate neoplasm (HP:0100787) | 2.23392998 |
| 92 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.23115551 |
| 93 | Pallor (HP:0000980) | 2.22833923 |
| 94 | Oral leukoplakia (HP:0002745) | 2.22688647 |
| 95 | Leukocytosis (HP:0001974) | 2.21614845 |
| 96 | Recurrent cutaneous fungal infections (HP:0011370) | 2.20775473 |
| 97 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.20775473 |
| 98 | Lymphopenia (HP:0001888) | 2.19519177 |
| 99 | Abnormality of eosinophils (HP:0001879) | 2.18828865 |
| 100 | B lymphocytopenia (HP:0010976) | 2.18694505 |
| 101 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.17949361 |
| 102 | Agammaglobulinemia (HP:0004432) | 2.17892237 |
| 103 | Bone marrow hypocellularity (HP:0005528) | 2.17332544 |
| 104 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.17247588 |
| 105 | 3-Methylglutaconic aciduria (HP:0003535) | 2.17124734 |
| 106 | CNS demyelination (HP:0007305) | 2.16760191 |
| 107 | Cellular immunodeficiency (HP:0005374) | 2.16440587 |
| 108 | Abnormality of B cell number (HP:0010975) | 2.14118151 |
| 109 | Gastrointestinal infarctions (HP:0005244) | 2.14046639 |
| 110 | Optic disc pallor (HP:0000543) | 2.12054989 |
| 111 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.10565703 |
| 112 | Exercise intolerance (HP:0003546) | 2.10350154 |
| 113 | IgA deficiency (HP:0002720) | 2.10243165 |
| 114 | Stomatitis (HP:0010280) | 2.10016350 |
| 115 | Respiratory failure (HP:0002878) | 2.08716308 |
| 116 | Basal ganglia calcification (HP:0002135) | 2.07980229 |
| 117 | Poor head control (HP:0002421) | 2.07764147 |
| 118 | Abnormality of the prostate (HP:0008775) | 2.07733499 |
| 119 | Basal cell carcinoma (HP:0002671) | 2.06788981 |
| 120 | Type I transferrin isoform profile (HP:0003642) | 2.05726254 |
| 121 | Abnormality of the preputium (HP:0100587) | 2.05255495 |
| 122 | Abnormality of the fingertips (HP:0001211) | 2.03844796 |
| 123 | Gastrointestinal inflammation (HP:0004386) | 2.03826857 |
| 124 | Abnormality of lateral ventricle (HP:0030047) | 2.03264669 |
| 125 | Hypochromic anemia (HP:0001931) | 2.03084403 |
| 126 | Albinism (HP:0001022) | 2.02432967 |
| 127 | Posterior subcapsular cataract (HP:0007787) | 2.02331266 |
| 128 | Progressive inability to walk (HP:0002505) | 2.01078308 |
| 129 | Poikiloderma (HP:0001029) | 2.00626500 |
| 130 | Leukopenia (HP:0001882) | 1.99458373 |
| 131 | Clubbing of toes (HP:0100760) | 1.98582498 |
| 132 | Premature ovarian failure (HP:0008209) | 1.98216425 |
| 133 | Hypergammaglobulinemia (HP:0010702) | 1.97865235 |
| 134 | Periodontitis (HP:0000704) | 1.97313645 |
| 135 | Neutropenia (HP:0001875) | 1.96574325 |
| 136 | Duodenal stenosis (HP:0100867) | 1.94968549 |
| 137 | Small intestinal stenosis (HP:0012848) | 1.94968549 |
| 138 | Attenuation of retinal blood vessels (HP:0007843) | 1.94411948 |
| 139 | Methylmalonic aciduria (HP:0012120) | 1.94223965 |
| 140 | Microretrognathia (HP:0000308) | 1.93032276 |
| 141 | Epistaxis (HP:0000421) | 1.92907842 |
| 142 | Abnormality of methionine metabolism (HP:0010901) | 1.92086331 |
| 143 | Breast hypoplasia (HP:0003187) | 1.92056717 |
| 144 | Increased IgE level (HP:0003212) | 1.90191028 |
| 145 | Rough bone trabeculation (HP:0100670) | 1.90115314 |
| 146 | Abnormality of chromosome stability (HP:0003220) | 1.89662557 |
| 147 | Osteomyelitis (HP:0002754) | 1.89573015 |
| 148 | Abnormality of the astrocytes (HP:0100707) | 1.89157881 |
| 149 | Astrocytoma (HP:0009592) | 1.89157881 |
| 150 | Patellar aplasia (HP:0006443) | 1.88525705 |
| 151 | Macrocytic anemia (HP:0001972) | 1.88190464 |
| 152 | Recurrent pneumonia (HP:0006532) | 1.87908390 |
| 153 | Lethargy (HP:0001254) | 1.87658281 |
| 154 | Gingivitis (HP:0000230) | 1.87396577 |
| 155 | Methylmalonic acidemia (HP:0002912) | 1.86575904 |
| 156 | Abnormality of midbrain morphology (HP:0002418) | 1.85178440 |
| 157 | Molar tooth sign on MRI (HP:0002419) | 1.85178440 |
| 158 | Skin ulcer (HP:0200042) | 1.84561915 |
| 159 | Abnormality of reticulocytes (HP:0004312) | 1.84163620 |
| 160 | Interstitial pulmonary disease (HP:0006530) | 1.84136285 |
| 161 | Absent thumb (HP:0009777) | 1.83422146 |
| 162 | Impaired platelet aggregation (HP:0003540) | 1.82789363 |
| 163 | Abnormal platelet function (HP:0011869) | 1.82789363 |
| 164 | Urticaria (HP:0001025) | 1.82450014 |
| 165 | Constricted visual fields (HP:0001133) | 1.82282773 |
| 166 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.82248575 |
| 167 | Secondary amenorrhea (HP:0000869) | 1.80406803 |
| 168 | Squamous cell carcinoma (HP:0002860) | 1.80329724 |
| 169 | Emotional lability (HP:0000712) | 1.79807605 |
| 170 | Pancreatic cysts (HP:0001737) | 1.79318307 |
| 171 | Premature graying of hair (HP:0002216) | 1.78926919 |
| 172 | Increased muscle lipid content (HP:0009058) | 1.78880316 |
| 173 | Hypoproteinemia (HP:0003075) | 1.77904283 |
| 174 | Respiratory difficulties (HP:0002880) | 1.75549986 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VRK2 | 3.79614853 |
| 2 | MAP4K1 | 3.37500423 |
| 3 | BUB1 | 2.98943953 |
| 4 | BLK | 2.96888667 |
| 5 | NUAK1 | 2.60319095 |
| 6 | WEE1 | 2.53556888 |
| 7 | TYK2 | 2.47318450 |
| 8 | NME2 | 2.44024530 |
| 9 | MAP4K2 | 2.37551063 |
| 10 | PLK4 | 2.22096727 |
| 11 | TRIM28 | 2.19690246 |
| 12 | STK10 | 2.12226615 |
| 13 | EIF2AK1 | 2.11190593 |
| 14 | NEK2 | 2.09443575 |
| 15 | CDC7 | 2.01715859 |
| 16 | SIK3 | 1.99780015 |
| 17 | PIM2 | 1.98634919 |
| 18 | MAP3K14 | 1.95225109 |
| 19 | PDK2 | 1.92262174 |
| 20 | ZAP70 | 1.91264418 |
| 21 | TXK | 1.89531712 |
| 22 | JAK3 | 1.79724861 |
| 23 | TBK1 | 1.77443822 |
| 24 | TSSK6 | 1.65159202 |
| 25 | TAF1 | 1.64565052 |
| 26 | IRAK4 | 1.59704452 |
| 27 | SRPK1 | 1.56967905 |
| 28 | BTK | 1.50744141 |
| 29 | EEF2K | 1.49292801 |
| 30 | BMPR1B | 1.47554107 |
| 31 | RPS6KA4 | 1.46688162 |
| 32 | TESK2 | 1.43497734 |
| 33 | IKBKB | 1.43304690 |
| 34 | IKBKE | 1.38606314 |
| 35 | KIT | 1.38446056 |
| 36 | MAP3K10 | 1.32544014 |
| 37 | TTK | 1.31579561 |
| 38 | BRSK2 | 1.30705890 |
| 39 | EIF2AK3 | 1.28974500 |
| 40 | GRK7 | 1.27692700 |
| 41 | ADRBK2 | 1.24166854 |
| 42 | PLK3 | 1.23943929 |
| 43 | TAOK3 | 1.23806034 |
| 44 | ATR | 1.22987864 |
| 45 | LRRK2 | 1.22760386 |
| 46 | PIM1 | 1.21369944 |
| 47 | RPS6KB2 | 1.20008996 |
| 48 | STK4 | 1.19512771 |
| 49 | MAP3K8 | 1.17928573 |
| 50 | KDR | 1.17885531 |
| 51 | GRK6 | 1.14911835 |
| 52 | CDK8 | 1.10136304 |
| 53 | FLT3 | 1.09717553 |
| 54 | TESK1 | 1.07499542 |
| 55 | CDK4 | 1.07040568 |
| 56 | CDK7 | 1.06660971 |
| 57 | DAPK1 | 1.06049072 |
| 58 | TEC | 1.04887639 |
| 59 | PASK | 1.04373305 |
| 60 | ACVR1B | 1.03005678 |
| 61 | SYK | 1.02740102 |
| 62 | AURKB | 1.02646453 |
| 63 | MAP2K3 | 1.02343124 |
| 64 | TAOK2 | 1.02050408 |
| 65 | MAP3K12 | 1.02046570 |
| 66 | NME1 | 1.00221767 |
| 67 | PLK1 | 0.98162777 |
| 68 | CSF1R | 0.98134282 |
| 69 | JAK1 | 0.97244113 |
| 70 | STK16 | 0.96784833 |
| 71 | BCR | 0.96371227 |
| 72 | ERN1 | 0.95959883 |
| 73 | CSNK1G3 | 0.95624694 |
| 74 | ERBB3 | 0.94738024 |
| 75 | TGFBR2 | 0.93914118 |
| 76 | MAP2K6 | 0.93417195 |
| 77 | CHUK | 0.92385206 |
| 78 | MKNK1 | 0.91170175 |
| 79 | GRK1 | 0.90541243 |
| 80 | NEK9 | 0.88940205 |
| 81 | BRSK1 | 0.87871863 |
| 82 | PAK4 | 0.86822563 |
| 83 | LYN | 0.85825324 |
| 84 | MAPK11 | 0.83269095 |
| 85 | CDK12 | 0.82940133 |
| 86 | LCK | 0.82818068 |
| 87 | VRK1 | 0.82545197 |
| 88 | CSNK1A1L | 0.81664954 |
| 89 | MKNK2 | 0.80803593 |
| 90 | IRAK3 | 0.80184303 |
| 91 | TGFBR1 | 0.79980712 |
| 92 | CSNK1G1 | 0.76223970 |
| 93 | MST4 | 0.75835892 |
| 94 | MAP3K13 | 0.70140982 |
| 95 | NEK1 | 0.69743053 |
| 96 | FGFR4 | 0.69473462 |
| 97 | MAPKAPK3 | 0.68229571 |
| 98 | ERBB4 | 0.67626999 |
| 99 | CHEK1 | 0.66812985 |
| 100 | PKN2 | 0.65551066 |
| 101 | PBK | 0.64600324 |
| 102 | CSK | 0.64245339 |
| 103 | BCKDK | 0.63734452 |
| 104 | ITK | 0.62634799 |
| 105 | EIF2AK2 | 0.61694861 |
| 106 | FRK | 0.60899313 |
| 107 | HCK | 0.60381014 |
| 108 | CCNB1 | 0.60041733 |
| 109 | CSNK1G2 | 0.59805164 |
| 110 | STK24 | 0.59325549 |
| 111 | TIE1 | 0.57245156 |
| 112 | MAP3K11 | 0.55652931 |
| 113 | RPS6KA5 | 0.54426980 |
| 114 | WNK3 | 0.53520067 |
| 115 | MARK3 | 0.53260630 |
| 116 | MAPKAPK2 | 0.52208725 |
| 117 | CHEK2 | 0.51909569 |
| 118 | STK3 | 0.51220415 |
| 119 | MAP3K5 | 0.51182517 |
| 120 | ZAK | 0.51087604 |
| 121 | CDK6 | 0.50834302 |
| 122 | AURKA | 0.50786778 |
| 123 | NLK | 0.50283758 |
| 124 | GRK5 | 0.49362485 |
| 125 | MUSK | 0.49156493 |
| 126 | TNK2 | 0.48325853 |
| 127 | PRKCI | 0.47613671 |
| 128 | ATM | 0.46891032 |
| 129 | DYRK3 | 0.46345259 |
| 130 | PAK1 | 0.44509958 |
| 131 | CSNK2A2 | 0.43777701 |
| 132 | TLK1 | 0.43689313 |
| 133 | CSNK2A1 | 0.43511187 |
| 134 | SCYL2 | 0.43252478 |
| 135 | CLK1 | 0.42543950 |
| 136 | INSRR | 0.34909979 |
| 137 | CDK9 | 0.31446640 |
| 138 | CAMKK2 | 0.29899538 |
| 139 | PRKCQ | 0.29283050 |
| 140 | MATK | 0.28774545 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 3.65745969 |
| 2 | Mismatch repair_Homo sapiens_hsa03430 | 3.02007278 |
| 3 | Proteasome_Homo sapiens_hsa03050 | 2.91883293 |
| 4 | Ribosome_Homo sapiens_hsa03010 | 2.71701503 |
| 5 | Base excision repair_Homo sapiens_hsa03410 | 2.46001290 |
| 6 | Homologous recombination_Homo sapiens_hsa03440 | 2.36338762 |
| 7 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.27116668 |
| 8 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.18482272 |
| 9 | * RNA polymerase_Homo sapiens_hsa03020 | 2.16517057 |
| 10 | * Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.15087561 |
| 11 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.12377442 |
| 12 | Spliceosome_Homo sapiens_hsa03040 | 2.10846086 |
| 13 | RNA transport_Homo sapiens_hsa03013 | 1.91534144 |
| 14 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.90503329 |
| 15 | Allograft rejection_Homo sapiens_hsa05330 | 1.88024999 |
| 16 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.85010536 |
| 17 | * Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.82366356 |
| 18 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.80893843 |
| 19 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.78751892 |
| 20 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.77263061 |
| 21 | Cell cycle_Homo sapiens_hsa04110 | 1.72327292 |
| 22 | Measles_Homo sapiens_hsa05162 | 1.71514870 |
| 23 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.71396569 |
| 24 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.70579353 |
| 25 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.69475352 |
| 26 | Parkinsons disease_Homo sapiens_hsa05012 | 1.65197195 |
| 27 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.59338666 |
| 28 | Leishmaniasis_Homo sapiens_hsa05140 | 1.56514229 |
| 29 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.55117356 |
| 30 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.53298967 |
| 31 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.51332487 |
| 32 | Legionellosis_Homo sapiens_hsa05134 | 1.48727606 |
| 33 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.45272420 |
| 34 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.44643589 |
| 35 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.43213663 |
| 36 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.35439839 |
| 37 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.34728684 |
| 38 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.31891361 |
| 39 | * Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.28144562 |
| 40 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.22224989 |
| 41 | Huntingtons disease_Homo sapiens_hsa05016 | 1.18633663 |
| 42 | Apoptosis_Homo sapiens_hsa04210 | 1.15680447 |
| 43 | Influenza A_Homo sapiens_hsa05164 | 1.10700450 |
| 44 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.09352786 |
| 45 | RNA degradation_Homo sapiens_hsa03018 | 1.08255255 |
| 46 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.08087649 |
| 47 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.07978941 |
| 48 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.07787236 |
| 49 | Shigellosis_Homo sapiens_hsa05131 | 1.03310789 |
| 50 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.02757814 |
| 51 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.00320923 |
| 52 | Viral myocarditis_Homo sapiens_hsa05416 | 0.97825364 |
| 53 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.96466723 |
| 54 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.96113505 |
| 55 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.95763207 |
| 56 | Sulfur relay system_Homo sapiens_hsa04122 | 0.95411008 |
| 57 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.92994251 |
| 58 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.92413088 |
| 59 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.92072518 |
| 60 | Asthma_Homo sapiens_hsa05310 | 0.91146940 |
| 61 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.90049975 |
| 62 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.88648209 |
| 63 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.86661380 |
| 64 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.86218904 |
| 65 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.86014775 |
| 66 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.85917699 |
| 67 | Basal transcription factors_Homo sapiens_hsa03022 | 0.85614614 |
| 68 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.85604724 |
| 69 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.85021439 |
| 70 | Hepatitis B_Homo sapiens_hsa05161 | 0.84997755 |
| 71 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.83529988 |
| 72 | * Purine metabolism_Homo sapiens_hsa00230 | 0.83402786 |
| 73 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.79878679 |
| 74 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.78143021 |
| 75 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.76205791 |
| 76 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.74825340 |
| 77 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.74445922 |
| 78 | Alzheimers disease_Homo sapiens_hsa05010 | 0.73909324 |
| 79 | Peroxisome_Homo sapiens_hsa04146 | 0.71483059 |
| 80 | HTLV-I infection_Homo sapiens_hsa05166 | 0.70774650 |
| 81 | Pertussis_Homo sapiens_hsa05133 | 0.69633920 |
| 82 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.68076971 |
| 83 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.67740398 |
| 84 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.66903542 |
| 85 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.66063031 |
| 86 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.65799748 |
| 87 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.64818902 |
| 88 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.64506864 |
| 89 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.63881052 |
| 90 | Tuberculosis_Homo sapiens_hsa05152 | 0.63354001 |
| 91 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.59893397 |
| 92 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.59710874 |
| 93 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.59298109 |
| 94 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.57154861 |
| 95 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.56778858 |
| 96 | Hepatitis C_Homo sapiens_hsa05160 | 0.55997215 |
| 97 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.53434434 |
| 98 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.53369831 |
| 99 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.52989805 |
| 100 | Other glycan degradation_Homo sapiens_hsa00511 | 0.52874857 |
| 101 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.51052158 |
| 102 | Galactose metabolism_Homo sapiens_hsa00052 | 0.50051567 |
| 103 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.49305290 |
| 104 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.48631037 |
| 105 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.47798251 |
| 106 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.46843222 |
| 107 | Protein export_Homo sapiens_hsa03060 | 0.45177692 |
| 108 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.45055831 |
| 109 | Malaria_Homo sapiens_hsa05144 | 0.45002670 |
| 110 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.44783712 |
| 111 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.44156315 |
| 112 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.43734974 |
| 113 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.43606478 |
| 114 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.42517917 |
| 115 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.41446711 |
| 116 | Carbon metabolism_Homo sapiens_hsa01200 | 0.41049933 |
| 117 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.40599847 |
| 118 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.39215112 |
| 119 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.38045218 |
| 120 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.37734767 |
| 121 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.37444297 |
| 122 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.36929421 |
| 123 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.36852137 |
| 124 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.36142440 |
| 125 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.35903022 |
| 126 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.35649241 |
| 127 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.34535047 |
| 128 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.34392955 |
| 129 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.34189405 |
| 130 | Lysosome_Homo sapiens_hsa04142 | 0.34155532 |
| 131 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.34072795 |
| 132 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.32684094 |
| 133 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.31893277 |
| 134 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.30889952 |
| 135 | Phototransduction_Homo sapiens_hsa04744 | 0.30387118 |
| 136 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.29713158 |
| 137 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.28750541 |
| 138 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.27790277 |

